Submission
Abstracts should be e-mailed according to the following instructions
- Abstract length: max. 300 words
- E-mail should include a statement on whether your abstract should be considered for an oral presentation, a poster presentation, or both
- E-mail should include your affiliation and field of research/work
- Abstract submission deadline: 10 April 2026, 23:59 CEST
Scope
To allow for researchers and practitioners from different fields and disciplines to present their work, the programme includes a few selected talks (10 min) and a poster session.
We invite abstracts on a wide range of topics related to diversity, (prote)omics/the (life) sciences, and/or Open Science. This topics include, but are not limited to:
- concepts of diversity, difference, representation, inclusion, etc. in (prote)omics or the (life) sciences
- quantitative/qualitative analysis on the current diversity, difference, representation, inclusion, etc. in (prote)omics study and/or researcher populations
- normative/ethical aspects of diversity, difference, representation, inclusion, etc. in (prote)omics or the (life) sciences
- policies/approaches on diversity, difference, representation, inclusion, etc. in (prote)omics or the (life) sciences
- approaches to working with diverse study or researcher populations or doing (prote)omics in different research contexts (theoretical work or practical cases)
- the benefits and pitfalls of various forms of diversity, difference, representation, inclusion, etc. in (prote)omics or the (life) sciences
- the relevant dimensions of difference in (prote)omics study and/or researcher populations
- the impact of Open Science frameworks on equity and inclusion in research
- ...
While the symposium aims to open up conversations on diversity in proteomics (and metabolomics, ...), we also encourage abstracts on aspects of diversity in other omics fields or the (life) sciences more broadly. This to bring expertise from different backgrounds together to start conversations on diversity in the proteomics field.